Recruiting

Back to Focal Segmental Glomerulosclerosis trials

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(69 sites)

United States

Investigational Site Number : 8400007, Birmingham, Alabama

Investigational Site Number : 8400015, Orange, California

Investigational Site Number : 8400012, San Francisco, California

Investigational Site Number : 8400025, Tampa, Florida

Investigational Site Number : 8400014, Chicago, Illinois

Investigational Site Number : 8400017, Hinsdale, Illinois

Investigational Site Number : 8400010, Ann Arbor, Michigan

Investigational Site Number : 8400019, Edina, Minnesota

Investigational Site Number : 8400018, Las Vegas, Nevada

Investigational Site Number: 8400028, Albuquerque, New Mexico

Investigational Site Number : 8400001, New York, New York

Investigational Site Number : 8400021, Chapel Hill, North Carolina

Investigational Site Number : 8400024, Dallas, Texas

Argentina

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 0320002, Córdoba

Australia

Investigational Site Number : 0360003, Garran, Australian Capital Territory

Investigational Site Number : 0360001, Parkville, Victoria

Brazil

Investigational Site Number : 0760002, São Paulo

Investigational Site Number : 0760001, São Paulo

Canada

Investigational Site Number : 1240002, London, Ontario

Investigational Site Number : 1240001, Montreal, Quebec

Investigational Site Number : 1240005, Montreal, Quebec

Investigational Site Number : 1240006, Québec, Quebec

Chile

Investigational Site Number : 1520003, Temuco, La Araucanía

Investigational Site Number : 1520002, Santiago, Reg Metropolitana de Santiago

China

Investigational Site Number : 1560001, Beijing

Investigational Site Number : 1560003, Chengdu

Investigational Site Number : 1560004, Shanghai

Czechia

Investigational Site Number : 2030002, Olomouc

Investigational Site Number : 2030001, Prague

France

Investigational Site Number : 2500002, Créteil

Investigational Site Number : 2500001, Paris

Germany

Investigational Site Number : 2760002, Berlin

Investigational Site Number : 2760003, Hanover

Greece

Investigational Site Number : 3000002, Athens

Investigational Site Number : 3000001, Heraklion

Investigational Site Number : 3000003, Ioannina

Hungary

Investigational Site Number : 3480001, Budapest

Italy

Investigational Site Number : 3800002, Florence, Firenze

Investigational Site Number : 3800003, Naples, Napoli

Investigational Site Number : 3800001, Brescia

Mexico

Investigational Site Number : 4840005, Mexico City, Mexico City

Investigational Site Number : 4840001, Mexico City, Mexico City

Investigational Site Number : 4840003, Monterrey, Nuevo León

Netherlands

Investigational Site Number : 5280001, Amsterdam

Poland

Investigational Site Number : 6160004, Poznan, Greater Poland Voivodeship

Investigational Site Number : 6160001, Lodz, Lódzkie

Investigational Site Number : 6160002, Opole, Opole Voivodeship

Portugal

Investigational Site Number : 6200003, Lisbon

Investigational Site Number : 6200002, Porto

Slovakia

Investigational Site Number : 7030003, Banská Bystrica

Investigational Site Number : 7030004, Bratislava

Investigational Site Number : 7030001, Martin

Spain

Investigational Site Number : 7240001, Barcelona, Barcelona [Barcelona]

Investigational Site Number : 7240004, Barcelona, Catalunya [Cataluña]

Investigational Site Number : 7240005, Seville, Sevilla

Investigational Site Number : 7240002, Córdoba

Investigational Site Number : 7240008, Madrid

Investigational Site Number : 7240007, Madrid

Investigational Site Number : 7240003, Valencia

Taiwan

Investigational Site Number : 1580001, Taichung

Investigational Site Number : 1580002, Taipei

Turkey (Türkiye)

Investigational Site Number : 7920001, İzmit

Investigational Site Number : 7920002, Kayseri

United Kingdom

Investigational Site Number : 8260001, Leicester, Leicestershire

Investigational Site Number : 8260004, Salford, Manchester

Investigational Site Number : 8260005, Oxford, Oxfordshire